CSBR:NASDAQ
Champions Oncology Inc
$4.65
0.00%
(0.00) 1D
Nov 12, 3:04:37 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
64.72M
Avg. vol.
8.16K
Volume
7.00
52-wk high
$8.31
52-wk low
$4.59
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Mkt. cap
64.72M
Avg. vol.
8.16K
Volume
7.00
52-wk high
$8.31
52-wk low
$4.59
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
Reuters
·
22 minutes ago
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
Yahoo Finance
·
39 minutes ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
FOREX.com
·
2 hours ago
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com